Enable Injections Introduces First Multi-Vial/Multi-Syringe Biologics Delivery System For Several Pharma Partners at BIO 2017
SAN DIEGO, June 19, 2017 /PRNewswire/ -- Enable Injections, Inc. the developer of advanced large volume wearable injectors (LVWI) for subcutaneous delivery of biologics and high volume drugs, today announced a new single, partial or multi-vial/syringe transfer system for filling its LVWIs. The system provides maximum flexibility by allowing the use of single or multiple vials and single or multiple syringes. It can also be used for variable dosing dependent on a patient's weight. The new biologics delivery tool has attracted additional development and commercial projects from Enable Injections' pharmaceutical partners and will be showcased for the first time at the BIO International Convention meeting in San Diego, June 19-22, 2017.
The small hand held Enable multi-vial transfer system can accommodate any pharmaceutical primary container closure. When multiple vials/syringes–or portions of a vial/syringe–are required to administer the prescribed dose, each vial/syringe is easily attached to the Enable Injector with its own screw-on adapter to reduce any chance of contamination.
A second transfer system for mixing and transferring lyophilized formulations or for mixing two liquid formulations is also available, with both vials attached to quickly, simultaneously fill the Enable Injector.
"We are grateful for the close collaboration with our forward-thinking pharmaceutical partners," said Enable Injections President and CEO Michael D. Hooven. "Advances in drug-device combination products such as this new, small multi-vial system come about as a result of a joint commitment to significantly improving the patient experience. We have responded to our pharma partners and to patients by developing a system that provides maximum flexibility and ease of use with a minimum of waste."
The Enable Large Volume Wearable Injector
Once filled from one or multiple vials/syringes, the small, lightweight pain- and error-minimizing Enable Injector adheres to the body. With its pressure-sensing capabilities, it comfortably delivers biologic doses as large as 50mL with the push of a button, no needle in sight. Self-administered by patients at home or work, the Enable Injections platform provides an alternative to costly intravenous infusions in a healthcare setting. Also in development by Enable is an app-connected device that is widely expected to lower overall healthcare costs while positively impacting outcomes by boosting compliance.
LVWI Advances Presentation
A presentation on the latest LVWI advances will take place Wednesday, June 21 at 5:00 pm in Company Presentation Theater 1.
Please visit us at BIO2017 Booth 327.
About Enable Injections
Founded February 2010 by medical device industry veterans, Cincinnati, OH-based Enable Injections develops and manufactures wearable devices that allow easy, comfortable patient self-administration of large volume/high viscosity drugs for pharmaceutical and biotechnology industry investigational use. The Enable body-worn injector utilizes any standard container closure system, including syringe or vial; automatically warms and can automatically mix lyophilized solutions. For more information please visit www.enableinjections.com and follow us on www.twitter.com/EnableInjection.
SOURCE Enable Injections
Share this article